Li Xu

Li Xu

Auto-generated profile, based on publicly available information

Li Xu

Department of Clinical Laboratory, Department of Nephrology, the Second Hospital of Jilin University, Changchun, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2018 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
QZQiang Zhang
Qiang Zhang
YAYongshun Ai
Yongshun Ai
HDHuiqiu Dong
Huiqiu Dong
JWJunsong Wang
Junsong Wang
LXLi Xu
Li Xu

1 March 2020 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
XLXiaodan Lu
Xiaodan Lu
QZQiang Zhang
Qiang Zhang
LXLi Xu
Li Xu
XLXiuying Lin
Xiuying Lin
JFJianhua Fu
Jianhua Fu
YFYanqiu Fang
Yanqiu Fang
Zinc (Zn) has antioxidant effect in different types of organs and is closely associated with human health. The endometrial receptivity is one of the most important factors in the embryo implantation and development. However, the regulatory mechanism of Zn in endometrium tissue is still unclear. In the study, we found that plasma Zn level is significantly associated with female infertility, which is severely affecting female reproductive health. Primary endometrial stromal cells were isolated from female endometrium and cultured in laboratory. Zn chelator TPEN treatment reduced the expression of stem cell markers CD73, CD90 and CD105 and generated ROS in endometrial stromal cells. However, pre-treatment of Zn (zinc sulfate) is able to prevent TPEN-induced oxidative stress in vitro. By transcriptional profiling and GO analysis, we found that Zn increased the cellular pluripotency signaling and ECM-receptor interaction, but reduced the autophagy, endocytosis and nitrogen metabolism pathway. We further discovered the antioxidant function of Zn through PGC-1α/Nrf2 signaling pathway in the endometrial stromal cells. Zn-supplementation may open up an effective therapeutic approach for patients with oxidative stress-related endometrial diseases.